Menu

#CagRiseMa

1 post

Feed
1 of 1 post
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
📰
0Read More

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Business - Latest - Google News·7 days ago
#JILq6TJ8
#world#news#cnbc#women#cagrisema

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

15s